J Gartmann

1.7k total citations
25 papers, 343 citations indexed

About

J Gartmann is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, J Gartmann has authored 25 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in J Gartmann's work include Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer, Lipids, and Metabolism (5 papers). J Gartmann is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer, Lipids, and Metabolism (5 papers). J Gartmann collaborates with scholars based in United States, Germany and Switzerland. J Gartmann's co-authors include Johannes Czernin, Matthias Eiber, Wolfgang P. Fendler, Jérémie Calais, Ken Herrmann, Roger Slavik, Robert E. Reiter, Matthew B. Rettig, Pawan Gupta and Andrew Quon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine and Respiration.

In The Last Decade

J Gartmann

21 papers receiving 326 citations

Peers

J Gartmann
Honest Ndlovu South Africa
Albert R. Frank United States
Hatice Bilge Türkiye
Ashok Subramanian United Kingdom
Clare Cruickshank United Kingdom
Rose S. Wong United States
Yves J. L. Bodar Netherlands
S. F. Grebe Germany
J Gartmann
Citations per year, relative to J Gartmann J Gartmann (= 1×) peers Benjamin Shepherd

Countries citing papers authored by J Gartmann

Since Specialization
Citations

This map shows the geographic impact of J Gartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Gartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Gartmann more than expected).

Fields of papers citing papers by J Gartmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Gartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Gartmann. The network helps show where J Gartmann may publish in the future.

Co-authorship network of co-authors of J Gartmann

This figure shows the co-authorship network connecting the top 25 collaborators of J Gartmann. A scholar is included among the top collaborators of J Gartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Gartmann. J Gartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calais, Jérémie, Johannes Czernin, Pan Thin, et al.. (2021). Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312). Journal of Nuclear Medicine. 62(10). 1447–1456. 29 indexed citations
2.
Ferdinandus, Justin, Wolfgang P. Fendler, Jérémie Calais, et al.. (2020). Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial. European Urology Open Science. 19. e1215–e1216. 2 indexed citations
3.
Ferdinandus, Justin, Wolfgang P. Fendler, Jérémie Calais, et al.. (2020). Impact of 68 Ga-PSMA-11 PET on the Management of biochemically recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. Nuklearmedizin - NuclearMedicine. 2 indexed citations
4.
Fendler, Wolfgang P., Justin Ferdinandus, Johannes Czernin, et al.. (2020). Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. Journal of Nuclear Medicine. 61(12). 1793–1799. 80 indexed citations
5.
Fendler, Wolfgang P., Justin Ferdinandus, Jérémie Calais, et al.. (2020). Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.. Journal of Clinical Oncology. 38(6_suppl). 292–292. 1 indexed citations
6.
Calais, Jérémie, J Gartmann, Wesley R. Armstrong, et al.. (2020). Overall survival after 177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer: Post-hoc analysis of a prospective phase II trial.. Journal of Clinical Oncology. 38(15_suppl). 5549–5549. 3 indexed citations
7.
Calais, Jérémie, Francesco Ceci, Kathleen Nguyen, et al.. (2019). Prospective head-to-head comparison of 18F-fluciclovine and 68Ga-PSMA-11 PET/CT for localization of prostate cancer biochemical recurrence after primary prostatectomy.. Journal of Clinical Oncology. 37(7_suppl). 15–15. 7 indexed citations
8.
Calais, Jérémie, Wolfgang P. Fendler, Matthias Eiber, et al.. (2019). RESIST-PC phase 2 trial: 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5028–5028. 10 indexed citations
9.
Calais, Jérémie, Wolfgang P. Fendler, Matthias Eiber, et al.. (2017). Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. Journal of Nuclear Medicine. 59(3). 434–441. 118 indexed citations
10.
Calais, Jérémie, Johannes Czernin, Matthias Eiber, et al.. (2017). Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented. Journal of Nuclear Medicine. 58(11). 1793–1796. 23 indexed citations
11.
Frutiger, Adrian, et al.. (2008). Traumatisch bedingte pulmonale Pseudozysten. DMW - Deutsche Medizinische Wochenschrift. 109(28/29). 1116–1121. 1 indexed citations
12.
Hartmann, Karin, et al.. (1993). Taste disorders and terbinafine.. BMJ. 307(6895). 26.3–26. 26 indexed citations
13.
Hartmann, Katharina, M Kuhn, & J Gartmann. (1992). [Spontaneous reporting system for the assessment of new, unknown and rare undesirable effects of drugs].. PubMed. 122(38). 1409–13. 2 indexed citations
14.
Kuhn, Matthew J., et al.. (1987). [Radiological lung changes during an influenza epidemic in 2 schools for Army recruits].. PubMed. 76(20). 547–50. 1 indexed citations
15.
Gartmann, J. (1980). [Pneumococcal pneumonia: epidemiology, therapy, immunoprophylaxis].. PubMed. 110(35). 1258–65.
16.
Briner, J. & J Gartmann. (1978). [Glomerulonephritis in sarcoidosis].. PubMed. 108(11). 401–6. 5 indexed citations
17.
Gartmann, J. (1975). Doxycycline Concentrations in Lung Tissue, Bronchial Wall, and Bronchial Secretions. Chemotherapy. 21(1). 19–26. 17 indexed citations
18.
Gartmann, J. (1972). [Doxycycline concentrations in pulmonary tissue, bronchial wall and bronchial secretion].. PubMed. 102(41). 1484–6. 7 indexed citations
19.
Brunner, Andrea, et al.. (1970). [Diffuse interstitial lung diseases due to avian proteins].. PubMed. 100(43). 1823–5.
20.
Gartmann, J. (1962). Diagnostische Probleme des Morbus Boeck. Respiration. 19(Suppl. 1). 62–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026